Statement from 46 Organizations Wednesday, December 3rd, 2025 As the world faces unprecedented health challenges, the Middle East and North Africa (MENA) region is entering a critical phase marked by an accelerating health crisis.
Press Release – ITPC-MENA The Moroccan Agency for Medicines and Health Products (AMMPS) has just authorized the marketing of Ozempic®, an injectable semaglutide-based medication indicated for the treatment of type 2 diabetes. Administered once
Position Title: Consultant for Policy Brief Development on the Global Fund’s Impact in the MENA Region for GC8 Organization(s): ITPC-MENA and MENA H Coalition Duration of Consultancy: 5 effective working days Background : The Middle
🗓️ On May 13, 2025, during the 3rd Global Summit on Intellectual Property and Access to Medicines (GSIPA2M2025) held in Marrakech and co-organized by ITPC-MENA, a deeply emotional moment captured the audience. A powerful tribute was paid to Professor Hakima
This report provides a civil society analysis of the HIV prevention response, outlining the progress and gaps in five countries: Egypt, Jordan, Lebanon, Morocco, and Tunisia. The findings inform a set of key recommendations
Terms of Reference (ToR) for ConsultationDemand Creation for New Generation ARVs – Acceptance Study Among PLWHIV 1. Context and Justification The Middle East and North Africa (MENA) region faces a growing HIV epidemic, characterized
Joint press release FOR IMMEDIATE RELEASE MENA-H coalition urges urgent action to combat tuberculosis in the region, with emphasis on innovation and universal health coverage 2025, March 24 – On World Tuberculosis Day, the
At the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco, results were presented from a Phase II study examining the efficacy of a combination of lenacapavir (TN Sunlenca) and two broadly
Context: The Middle East and North Africa (MENA) region continues to face major public health challenges related to HIV/AIDS. Key populations, including young people, men who have sex with men, sex workers, and injecting
The National Institute of Industrial Property of Argentina (INPI) has rejected patent applications from Gilead for the drug lenacapavir – an innovative long-acting injectable drug that has proven effective as an option for PrEP
